Tarek Nahle, Postdoctoral Research Fellow at Augusta University, shared a post on X:
“Excited to share an Augusta University/Wellstar Health System study at AHA25. Join us for the presentation, ‘Treatment Modality and Cardiovascular Mortality in Breast Cancer: A SEER and Single-Center Analysis by Stage and Receptor Subtype’ on November 9th.
We will discuss trends in cardiovascular mortality in different disease profiles, with risk associations according to treatment selection.
This study is important in this era of evolving cardiooncology practice, with increased awareness, screening, and management of baseline and subsequent cardiovascular disease and risk factors.”
More posts featuring Tarek Nahle.